The effect of milrinone on metabolism after cardiopulmonary bypass

Journal of Cardiovascular Surgery

Volumn 49, Issue 1, 2008, Pages 113-118

  Tatlis, Alex ^a,b   Papapkonstantinou, C ^a   Toumbouras, M ^a   Gerolioliou, K ^a   Spanos, P ^a  

^a AHEPA UNIVERSITY HOSPITAL   (Greece)

^b NONE   (Greece)

Author keywords

Cardiopulmonary bypass; Epinephrine; Metabolism; Milrinone; Phoshodiesterase inhibitors

Indexed keywords

ADRENALIN; GLUCOSE; INOTROPIC AGENT; LACTIC ACID; MILRINONE; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL FEATURE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; ELECTIVE SURGERY; EXTRACORPOREAL CIRCULATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART DISEASE; HEART FAILURE; HEART PRELOAD; HUMAN; HYPOTENSION; LACTATE BLOOD LEVEL; LUNG CAPILLARY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEAN ARTERIAL PRESSURE; PULMONARY HYPERTENSION; TISSUE METABOLISM; VASODILATATION;

ACID-BASE EQUILIBRIUM; ACIDOSIS; ADULT; AGED; BLOOD GLUCOSE; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; EPINEPHRINE; FEMALE; HEMODYNAMICS; HUMANS; INFUSIONS, PARENTERAL; LACTIC ACID; MALE; MIDDLE AGED; MILRINONE; PROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 40449109466     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (11)

1. Zhou SX, Qiu HB, Huang YZ, Yang YI, Zheng RQ. Effects of norepinephrine, epinephrine, and norepinephrine-dobutamine on systemic and gastric mucosal oxygenation in septic shock. Acta Pharmacol Sin 2002;23:654-8.
2. Unverferth DV, Blanford N, Kates RE, Eier CV. Tolerance to dobutamine after 72 h continuous infusion. Am J Med 1980;69:262-6.
3. Alousi AA, Canter JM, Montenaro MJ, Fort DJ, Ferrari RA. Cardiotonic activity of milrinone, a new and potent cardiac bipyridine, on the normal and failing heart of experimental animals. J Cardiovasc Pharrmacol 1983;5:792-803.
4. Orime Y, Shiono M, Hata H, Yagi S, Tsukamoto S, Okumura H et al. Effects of phoshodiesterase inhibitors after coronary artery bypass grafting. Jpn Circ J 1999;63:117-22.
5. Feneck RO. Intravenous milrinone following cardiac surgery. The European Milrinone Multicentre Trial Group. J Cardiothorac Vasc Anaesth 1992;6:563-7.
6. Levy JH, Bailey JM, Deed MG. Intravenous milrinone in cardiac surgery. Ann Thorac Surg 2002;73:325-30.
7. Feneck RO. Milrinone and postoperative pulmnary hypertension. J Cardiothorac Vasc Anaesth 1993;7(Suppl 1):21-3.
8. Mollhoff T, Loick H, Van Aken H, Schmidt C, Rolf N, Tian TDT et al. Milrinone Modulates Endotoxemia, systemic inflammation and subsequent acute phase response after cardiopulmonary bypas (CPB). Anesthesiology 1999;90:72-80.
9. Barham D, Trinder P. An improved colour reagent for the determination of blood lactate by the oxidase system. Analyst 1972;97:142-5.
10. Yamaura K, Okamoto H, Akiyosi K, Irita K, Taniyama T, Takahashi S. Effect of low-dose milrinone on gastric intramucosal pH and systemic inflammation after hypothermic cardiopulmonary bypass. J Cardiothorac Vasc Anaesth 2001;15:197-203.
11. Baruch L, Patacsil P, Hameed A, Pino I, Luh E. Pharmacodynamic effects of milrinone with and without a bolus loading infusion. Am Heart J 2000;141:e6.